Learning The Trade: Advice For Scientists Seeking Book Publishers

Learning The Trade: Advice For Scientists Seeking Book Publishers The well-publicized commercial successes of science books for the lay, or trade, market--going all the way back to The Double Helix by James Watson (New York, Atheneum Publishers, 1968), and through the more recent A Brief History of Time by Stephen Hawking (New York, Bantam Books, 1988)--provide indisputable evidence that science titles can have broad appeal and eve

Written bySusan Rabiner
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Learning The Trade: Advice For Scientists Seeking Book Publishers

The well-publicized commercial successes of science books for the lay, or trade, market--going all the way back to The Double Helix by James Watson (New York, Atheneum Publishers, 1968), and through the more recent A Brief History of Time by Stephen Hawking (New York, Bantam Books, 1988)--provide indisputable evidence that science titles can have broad appeal and even occasionally become mega-bestsellers. Less well-publicized have been those many science titles that never achieved such broad recognition, yet still returned handsome profits for their publishers.

TRADE BOOK TIPS Here are a few tips for the scientist thinking of writing a science book for trade publication: Good trade book authors are trade book readers. Before you begin to write your proposal, go to a good general-interest bookstore and read through the science titles on the shelves. Don't limit yourself to those in your own ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies